CIK 0001819576 · Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851710962
- Phone
- 919.328.4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $23,494,367
- in 17 filings, $12.2M under 10b5-1 plans
Net −$23,494,367. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-10 | Schundler Russell General Counsel | Option exercise 10b5-1 | +6,409 | 620,700 | ||
| 2026-07-10 | Schundler Russell General Counsel | Option exercise · Performance Stock Units 10b5-1 | −3,759 | 22,550 | ||
| 2026-07-10 | Schundler Russell General Counsel | Option exercise · Performance Stock Units 10b5-1 | −6,409 | 64,089 | ||
| 2026-07-10 | Saggar Rajeev Chief Medical Officer | Option exercise 10b5-1 | +3,531 | 177,238 | ||
| 2026-07-10 | Saggar Rajeev Chief Medical Officer | Option exercise 10b5-1 | +4,487 | 181,725 | ||
| 2026-07-10 | Saggar Rajeev Chief Medical Officer | Option exercise · Performance Stock Units 10b5-1 | −3,531 | 21,184 | ||
| 2026-07-10 | Saggar Rajeev Chief Medical Officer | Option exercise · Performance Stock Units 10b5-1 | −4,487 | 44,862 | ||
| 2026-07-10 | Moomaw Scott Chief Commercial Officer | Option exercise 10b5-1 | +3,108 | 187,666 | ||
| 2026-07-10 | Moomaw Scott Chief Commercial Officer | Option exercise 10b5-1 | +4,358 | 192,024 | ||
| 2026-07-10 | Moomaw Scott Chief Commercial Officer | Option exercise · Performance Stock Units 10b5-1 | −3,108 | 18,646 | ||
| 2026-07-10 | Moomaw Scott Chief Commercial Officer | Option exercise · Performance Stock Units 10b5-1 | −4,358 | 43,580 | ||
| 2026-07-10 | Boyle Dana Chief Accounting Officer | Option exercise 10b5-1 | +3,179 | 178,521 | ||
| 2026-07-10 | Boyle Dana Chief Accounting Officer | Option exercise · Performance Stock Units 10b5-1 | −3,179 | 31,787 | ||
| 2026-07-07 | Bloch Stephen M Director | Sale | −22,718 | $80.48 | $1.8M | 807,355 |
| 2026-07-07 | Bloch Stephen M Director | Sale | −27,282 | $81.31 | $2.2M | 780,073 |
| 2026-07-06 | Bloch Stephen M Director | Sale | −25,000 | $80.18 | $2.0M | 830,073 |
| 2026-07-01 | Bloch Stephen M Director | Sale | −24,147 | $79.45 | $1.9M | 855,926 |
| 2026-07-01 | Bloch Stephen M Director | Sale | −853 | $80.05 | $68K | 855,073 |
| 2026-06-22 | Bloch Stephen M Director | Sale | −69,500 | $75.54 | $5.3M | 910,573 |
| 2026-06-22 | Bloch Stephen M Director | Sale | −30,500 | $76.18 | $2.3M | 880,073 |
Page 7 of 18 · 344 trades